Search

Author/Creator Shah, Vandna

1. Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. (May 2018)

Authors:
Tutt, Andrew; Tovey, Holly; Cheang, Maggie; Kernaghan, Sarah; Kilburn, Lucy; Gazinska, Patrycja; Owen, Julie; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee, Peter; Brown, Robert; Chan, Stephen; Dowsett, Mitchell; Flanagan, James; Fox, Lisa; Grigoriadis, Anita; Gutin, Alexander; Harper-Wynne, Cat...
Journal:
Nature medicine
Issue:
Volume 24:Number 5(2018)
Page Start:
628
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Genetic predisposition to ductal carcinoma in situ of the breast. Issue 1 (December 2016)

Authors:
Petridis, Christos; Brook, Mark; Shah, Vandna; Kohut, Kelly; Gorman, Patricia; Caneppele, Michele; Levi, Dina; Papouli, Efterpi; Orr, Nick; Cox, Angela; Cross, Simon; dos-Santos-Silva, Isabel; Peto, Julian; Swerdlow, Anthony; Schoemaker, Minouk; Bolla, Manjeet; Wang, Qin; Dennis, Joe; Michailidou...
Journal:
Breast cancer research
Issue:
Volume 18:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. Issue 1 (December 2017)

Authors:
Shah, Vandna; Nowinski, Salpie; Levi, Dina; Shinomiya, Irek; Kebaier Ep Chaabouni, Narda; Gillett, Cheryl; Grigoriadis, Anita; Graham, Trevor; Roylance, Rebecca; Simpson, Michael; Pinder, Sarah; Sawyer, Elinor
Journal:
Breast cancer research
Issue:
Volume 19:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗